Close Menu
Daily Guardian
  • Home
  • News
  • Politics
  • Business
  • Entertainment
  • Lifestyle
  • Health
  • Sports
  • Technology
  • Climate
  • Auto
  • Travel
  • Web Stories
What's On

Tea and Coffee Packaging Machinery Market Outlook 2026-2035 Featuring Strategic Profiles of IMA Group, Syntegon Technology, Coesia Group, GEA Group, Tetra Pak and Regional Powerhouses

August 24, 2026

Canatu receives further reactor order from FST, validating its CNT technology for pellicle manufacturing

August 24, 2026

Practice Is the Sole Criterion for Testing Robots! DEEP Robotics' Six Industry Product Lines Make Their First Complete Debut at WRC 2026

August 24, 2026

IUX Launches New Education Webinar Series to Support Traders’ Financial Literacy

August 24, 2026

Goliath’s 2026 Drilling Expands Golden Gate Zone From 0.85 Km² To 1.17 Km² And Bonanza Zone From 1.27 Km² to 1.51 Km² And Remains Open For Expansion, Drilling Continues On The High-Grade Gold Surebet Discovery, Golden Triangle, B.C.

August 24, 2026
Facebook X (Twitter) Instagram
Finance Pro
Facebook X (Twitter) Instagram
Daily Guardian
Subscribe
  • Home
  • News
  • Politics
  • Business
  • Entertainment
  • Lifestyle
  • Health
  • Sports
  • Technology
  • Climate
  • Auto
  • Travel
  • Web Stories
Daily Guardian
Home » Yuhua Zhang, PhD, Named Chairholder of the Carolyn and Chuck Miller Endowed Chair for Vision Research
Press Release

Yuhua Zhang, PhD, Named Chairholder of the Carolyn and Chuck Miller Endowed Chair for Vision Research

By News RoomApril 17, 20264 Mins Read
Yuhua Zhang, PhD, Named Chairholder of the Carolyn and Chuck Miller Endowed Chair for Vision Research
Share
Facebook Twitter LinkedIn Pinterest Email

PASADENA, Calif., April 17, 2026 (GLOBE NEWSWIRE) — Doheny Eye Institute, one of the nation’s leading vision research institutions for nearly 80 years, named Yuhua Zhang, PhD, chairholder of the Carolyn and Chuck Miller Endowed Chair for Vision Research. This prestigious appointment recognizes Dr. Zhang’s leadership and transformative contributions to vision science and will support his ongoing research at Doheny.

Dr. Zhang is a Professor of Ophthalmology at University of California, Los Angeles, and a Principal Investigator leading a research laboratory at Doheny Eye Institute, where he is internationally recognized for developing advanced retinal imaging technologies that enable studying retinal structure, metabolism, and microvascular function, with unprecedented resolution, in the living eye. His work has advanced understanding of diseases such as age-related macular degeneration, diabetes, hypertension, and disorders affecting the brain’s small blood vessels.

“I am honored to receive the Carolyn and Chuck Miller Endowed Chair for Vision Research,” said Dr. Zhang. “This position will further support the innovative technologies my lab is developing, which will help drive forward our understanding of the human eye and the diseases that lead to vision loss.”

At Doheny, Dr. Zhang leads a multidisciplinary team developing next-generation imaging tools capable of capturing individual retinal cells with molecular contrast and blood flow in the tiny vessels of the retina. These innovations are revealing early biological changes associated with vision loss, helping pave the way for earlier diagnosis and improved treatment of blinding eye diseases. His research is supported by the National Institutes of Health, Research to Prevent Blindness, and other major funders, and has been published widely in leading scientific journals.

“Dr. Zhang conducts pioneering work in developing imaging tools that scientists and ophthalmologists can utilize to see the eye with incredible resolution, diagnose disease earlier and support our understanding of the biological mechanisms that lead to vision loss. His work supports the development of future therapies that could help prevent vision loss altogether,” said Deborah Ferrington, PhD, Chief Scientific Officer at Doheny. “His impressive contributions to vision science make Dr. Zhang greatly deserving of the Carolyn and Chuck Miller Endowed Chair.”

Originally trained in precision instrument engineering at Tianjin University in China, Dr. Zhang built his career across research institutions in China, New Zealand, Australia, and the United States before joining Doheny and UCLA in 2018. He also holds a faculty appointment in UCLA’s Department of Bioengineering.

“Establishing this endowed chair continues the legacy of my husband, Charles Miller, who championed innovation and technology,” commented Carolyn Miller, who established the Carolyn and Chuck Miller Endowed Chair for Vision Research. “Supporting Doheny Eye Institute – and Dr. Zhang – in their continued efforts to make life-changing advancements at the same campus in Pasadena where my husband once worked is something I am proud to contribute to.”

About the Carolyn and Chuck Miller Endowed Chair for Vision Research
The Carolyn and Chuck Miller Endowed Chair for Vision Research was established through a $2.5 million gift from Carolyn Miller in honor of her late husband, Charles D. Miller, former Chairman and Chief Executive Officer of Avery Dennison located at 150 N. Orange Grove Blvd., Pasadena — what is now Doheny’s headquarters. Chuck Miller was a visionary business builder and civic leader whose 47-year career at Avery Dennison helped guide the company’s growth into a global Fortune 500 organization. Serving as CEO for 21 years, and Chairman for 17, he shaped the company’s long-term strategy, culture, and success. He lived with age-related macular degeneration, a personal experience that underscored the importance of advancing vision research.

Carolyn Miller is a dedicated philanthropist and civic leader who remains deeply engaged in the Pasadena community. Through this endowed chair, she honors her late husband’s legacy while supporting vision research, education, and service at Doheny Eye Institute, advancing scientific discovery aimed at preserving sight for future generations.

About Doheny Eye Institute
Doheny Eye Institute is one of the nation’s leading vision research institutions with a history dating back nearly 80 years. Doheny scientists remain at the forefront of vision science tackling some of the most pressing challenges in eye health—from diabetic retinopathy and age-related macular degeneration to uveitis and neuro-ophthalmic disease. Our teams are advancing the frontiers of artificial intelligence, eye imaging, and biomarker discovery—pioneering work that is redefining how we diagnose, treat, and ultimately prevent vision loss.

Since 2013, the Doheny and UCLA Stein Eye Institute affiliation combines the strength, reputation, and distinction of two of the nation’s top eye institutions to advance vision research, education, and patient care in Southern California.

For more information visit www.Doheny.org.

Contact:
Cecilia Zamudio
Doheny Eye Institute
[email protected]

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/ec2c0ef4-41b8-4d9c-b626-5afa01e65291

Share. Facebook Twitter Pinterest LinkedIn Tumblr Email

Keep Reading

Tea and Coffee Packaging Machinery Market Outlook 2026-2035 Featuring Strategic Profiles of IMA Group, Syntegon Technology, Coesia Group, GEA Group, Tetra Pak and Regional Powerhouses

Canatu receives further reactor order from FST, validating its CNT technology for pellicle manufacturing

Practice Is the Sole Criterion for Testing Robots! DEEP Robotics' Six Industry Product Lines Make Their First Complete Debut at WRC 2026

IUX Launches New Education Webinar Series to Support Traders’ Financial Literacy

Goliath’s 2026 Drilling Expands Golden Gate Zone From 0.85 Km² To 1.17 Km² And Bonanza Zone From 1.27 Km² to 1.51 Km² And Remains Open For Expansion, Drilling Continues On The High-Grade Gold Surebet Discovery, Golden Triangle, B.C.

MEXC Launches RealStocks API with 0 Commissions for Quantitative Traders

PFAS-Free Food Packaging Market Opportunity Forecast 2026-2035 | Regulatory Momentum and Sustainability Demand Accelerate PFAS-Free Food Packaging

High Power Microwave Weapons Market Report 2026-2035: Features Profiles of Raytheon (RTX), Epirus, CSGC / Norinco, Lockheed Martin, CASC and Other Regional Powerhouses

WONDERLAB and United Family Healthcare | Global Health Summit 2026

Editors Picks

Canatu receives further reactor order from FST, validating its CNT technology for pellicle manufacturing

August 24, 2026

Practice Is the Sole Criterion for Testing Robots! DEEP Robotics' Six Industry Product Lines Make Their First Complete Debut at WRC 2026

August 24, 2026

IUX Launches New Education Webinar Series to Support Traders’ Financial Literacy

August 24, 2026

Goliath’s 2026 Drilling Expands Golden Gate Zone From 0.85 Km² To 1.17 Km² And Bonanza Zone From 1.27 Km² to 1.51 Km² And Remains Open For Expansion, Drilling Continues On The High-Grade Gold Surebet Discovery, Golden Triangle, B.C.

August 24, 2026

Latest News

MEXC Launches RealStocks API with 0 Commissions for Quantitative Traders

August 24, 2026

PFAS-Free Food Packaging Market Opportunity Forecast 2026-2035 | Regulatory Momentum and Sustainability Demand Accelerate PFAS-Free Food Packaging

August 24, 2026

High Power Microwave Weapons Market Report 2026-2035: Features Profiles of Raytheon (RTX), Epirus, CSGC / Norinco, Lockheed Martin, CASC and Other Regional Powerhouses

August 24, 2026
Facebook X (Twitter) Pinterest TikTok Instagram
© 2026 Daily Guardian Canada. All Rights Reserved.
  • Privacy Policy
  • Terms
  • Advertise
  • Contact

Type above and press Enter to search. Press Esc to cancel.

Go to mobile version